Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Biodegradable polymer nanoparticles; Oral bioavailability; Poorly soluble drugs; Drug delivery; Solubility enhancement; Pharmaceutical technology

Introduction

Oral administration remains the preferred route for drug delivery due to its convenience, patient compliance, and cost-effectiveness. However, many drugs with poor aqueous solubility face challenges in achieving sufficient absorption and therapeutic efficacy when administered orally. Poorly soluble drugs often exhibit low bioavailability, necessitating strategies to enhance their solubility, stability, and absorption in the gastrointestinal (GI) tract [1].

Biodegradable polymer nanoparticles have garnered attention as effective carriers for enhancing the oral bioavailability of poorly soluble drugs. These nanoparticles are engineered from biocompatible and biodegradable polymers, such as poly(lactic-co-glycolic acid) (PLGA), poly(lactic acid) (PLA), and chitosan, among others. By encapsulating poorly soluble drugs within nanoparticles, their dissolution rate and gastrointestinal permeability can be improved, leading to enhanced absorption and bioavailability [2].

This article explores the application of biodegradable polymer nanoparticles for enhancing oral bioavailability of poorly soluble drugs. We discuss the design principles, mechanisms of drug delivery, and recent advancements in nanoparticle-based approaches to overcome the challenges associated with oral delivery. By highlighting these innovations, we aim to underscore the transformative potential of biodegradable polymer nanoparticles in pharmaceutical technology and drug development [3].

Importance of oral drug delivery

Oral administration remains the most preferred route due to its convenience and patient compliance. However, the effectiveness of this method is hindered by the low aqueous solubility of many drugs, leading to inadequate bioavailability and reduced therapeutic outcomes [4].

Challenges in oral delivery of poorly soluble drugs

The primary challenges include poor dissolution rates, instability in the gastrointestinal environment, and limited permeability across the intestinal epithelium. These factors collectively impede the efficient delivery and absorption of poorly soluble drugs [5].

Biodegradable polymer nanoparticles as a solution

Biodegradable polymer nanoparticles have emerged as a promising solution to these challenges. These nanoparticles can encapsulate poorly soluble drugs, enhancing their solubility, stability, and absorption. The biodegradable nature of the polymers ensures that they are safely metabolized and excreted from the body [6].

Mechanisms of enhanced bioavailability

The mechanisms through which biodegradable polymer nanoparticles enhance bioavailability include improved dissolution rates, protection from enzymatic degradation, and facilitated transport across the intestinal barrier. These mechanisms ensure that a higher concentration of the drug reaches systemic circulation [7].

Recent advancements and future prospects

Recent advancements in the design and development of biodegradable polymer nanoparticles have shown significant promise. This section will explore the latest research and future prospects in the application of these nanoparticles for the oral delivery of poorly soluble drugs, highlighting their potential to revolutionize pharmaceutical therapies [8].

Discussion

Design strategies of biodegradable polymer nanoparticles

Biodegradable polymer nanoparticles are designed with specific attributes to optimize drug delivery:

1. Polymer selection: Polymers like PLGA and PLA offer controlled release kinetics, biocompatibility, and biodegradability, ensuring safe and sustained drug release in the GI tract.
2. Particle size and surface properties: Nanoparticle size influences gastrointestinal transit and absorption. Surface modifications with mucoadhesive polymers or surfactants enhance nanoparticle stability and mucosal adhesion, facilitating prolonged drug release and absorption.
3. Drug encapsulation efficiency: Optimization of nanoparticle formulation parameters (e.g., polymer/drug ratio, solvent selection) ensures high drug loading capacity and encapsulation efficiency, critical for achieving therapeutic doses [9].

Mechanisms of drug delivery

Biodegradable polymer nanoparticles facilitate drug delivery through several mechanisms:

1. Enhanced solubility: Nanoparticles improve drug solubility by dispersing hydrophobic drugs in aqueous environments, preventing aggregation and enhancing dissolution rates upon oral administration.
2. Protection and stability: Encapsulation within nanoparticles protects drugs from enzymatic degradation and pH fluctuations in the GI tract, maintaining drug stability until absorption.
3. Mucosal permeation: Surface-modified nanoparticles interact with intestinal epithelial cells, promoting paracellular or transcellular transport pathways for enhanced drug absorption [10].

Advancements in pharmaceutical applications

Recent advancements in biodegradable polymer nanoparticles have expanded their applications across various therapeutic areas:

1. Anticancer agents: Nanoparticle formulations improve the oral bioavailability of chemotherapeutic drugs, such as paclitaxel and docetaxel, minimizing systemic toxicity and enhancing patient compliance.
2. Antimicrobial agents: Encapsulation of antimicrobial agents within nanoparticles enhances drug stability and absorption in treating infections, offering alternatives to parenteral administration.
3. Nutraceuticals and supplements: Nanoparticle-based delivery systems improve the bioavailability of vitamins, antioxidants, and dietary supplements, supporting nutritional supplementation and therapeutic benefits.

Future prospects and challenges

Despite significant progress, biodegradable polymer nanoparticles for oral drug delivery face challenges that warrant further research:

1. Biocompatibility and safety: Evaluating the long-term biocompatibility and potential toxicity of nanoparticle formulations remains crucial for clinical translation.
2. Scale-up and manufacturing: Scaling up production and optimizing manufacturing processes to ensure batch-to-batch consistency and regulatory compliance.
3. Clinical validation: Conducting rigorous preclinical and clinical studies to validate the efficacy, safety, and pharmacokinetics of nanoparticle-based formulations in humans.

Conclusion

Biodegradable polymer nanoparticles represent a versatile and promising approach to enhance the oral bioavailability of poorly soluble drugs. By improving drug solubility, stability, and absorption in the gastrointestinal tract, these nanoparticles offer solutions to longstanding challenges in oral drug delivery. Future research efforts should focus on refining nanoparticle designs, optimizing formulation parameters, and overcoming regulatory hurdles to accelerate their clinical translation and improve patient outcomes in pharmaceutical therapy.

References

1. Morsy AS, Soltan YA, Sallam SMA, Kreuzer M, Alencar SM, et al. (2015)Comparison of the in vitro efficiency of supplementary bee propolis extracts of different origin in enhancing the ruminal degradability of organic matter and mitigating the formation of methane.Animal Feed Science and Technology 199: 51–60.

Google Scholar, Crossref

2. Soltan YA, Patra AK (2020)Bee propolis as a natural feed additive: Bioactive compounds and effects on ruminal fermentation pattern as well as productivity of ruminants.Indian Journalof Animal Health 59: 50–61.

Google Scholar, Crossref

3. Ristivojevića P, Trifkovićb J, Andrić FB, Milojković-Opsenicab D (2015)Poplartype Propolis: Chemical Composition, Botanical Origin and Biological Activity.Natural Product Communications 10: 1869–1876.

Indexed at, Google Scholar, Crossref

4. Machado BAS, Silva RPD, Barreto GDA, Costa SS, Da Silva DF, et al. (2016)Chemical composition and biological activity of extracts obtained by supercritical extraction and ethanolic extraction of brown, green and red propolis derived from different geographic regions in Brazil.PLoS ONE 11: 1–26.

Google Scholar, Crossref

5. Papachroni D, Graikou K, Kosalec I, Damianakos H, Ingram V, et al. (2015)Phytochemical analysis and biological evaluation of selected african propolis samples from Cameroon and congo.Natural Product Communications 10: 67–70.

Indexed at, Google Scholar, Crossref

6. Ozdal T, Sari-kaplan G, Mutlu-altundag E, Boyacioglu D (2018)Evaluation of Turkish propolis for its chemical composition , antioxidant capacity , anti- proliferative effect on several human breast cancer cell lines and proliferative effect on fibroblasts and mouse mesenchymal stem cell line.Journal of Apicultural Research 1–12.

Google Scholar, Crossref

7. Wozniak M, Mrówczynska L, Agnieszka W, Tomasz R, Izabela R, et al. (2019)The role of seasonality on the chemical composition , antioxidant activity and cytotoxicity of Polish propolis in human erythrocytes.29: 301–308.

Google Scholar

8. Tomazzoli MM, Zeggio ARS, Neto RDP, Specht L, Costa C, et al. (2020)Botanical source investigation and evaluation of the effect of seasonality on brazilian propolis from apis mellifera L.Scientia Agricola 77: 1-10

Google Scholar, Crossref

9. Mendez-Pfeiffer P, Alday E, Carreño AL, Hernández-Tánori J, Montaño-Leyva B, et al. (2020)Seasonality modulates the cellular antioxidant activity and antiproliferative effect of sonoran desert propolis.Antioxidants 9: 1–15.

Indexed at, Google Scholar, Crossref

10. Anderson SE, Meade BJ (2014)Potential health effects associated with dermal exposure to occupational chemicals.Environ Health Insights 8: 51–62.

Indexed at, Google Scholar, Crossref